FY2025 EPS Estimate for Arcus Biosciences Reduced by Analyst
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Equities research analysts at HC Wainwright dropped their FY2025 earnings per share estimates for Arcus Biosciences in a research note issued on Tuesday, February 18th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings per share of ($4.69) for the year, down from […]
